Abiopharma

General Announcement: Net Asset Value ("NAV") per Unit

General Announcement: Net Asset Value ("NAV") per Unit

General Announcement: Net Asset Value ("NAV") per Unit

General Announcement: Net Asset Value ("NAV") per Unit

General Announcement: Net Asset Value ("NAV") per Unit

General Announcement: Net Asset Value ("NAV") per Unit

General Announcement: Net Asset Value ("NAV") per Unit

NEON attributes changed: Attr: Fin_status N -> D;

Gold Reserve anuncia nuevas ofertas para liquidar derechos de valor contingente y beneficios, ofrece una alternativa a los titulares de opciones y modifica su plan de incentivos en acciones

CAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit

Rosen Law Firm Encourages Gildan Activewear Inc. Investors to Inquire About Securities Class Action Investigation - GIL

GOLDMAN SACHS GROUP INC 🟡 adjusted position in 479.1K shares (2 derivative) of Attovia Therapeutics, Inc. (ATTO) at $22.19 ($12.5M) Transaction Date: Aug 05, 2026 | Filing ID: 000495

📋 Sumita Ray (Officer) plans to sell 9K shares of CUE BIOPHARMA, INC. (at $30.14 each, total $266K) Filed: Aug 13, 2026 | ID: 000006

RCM Technologies, Inc. Announces Second Quarter 2026 Results

BOSTON OMAHA Corp 🔴 sold 360.0K shares of Sky Harbour Group Corp (SKYH) at $10.00 ($3.6M) Transaction Date: Aug 11, 2026 | Filing ID: 027810